International Clinical Trial: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Ascending Phase I Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RB0026 Injection in Healthy Chinese Adults

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600135046) titled 'A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Ascending Phase I Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RB0026 Injection in Healthy Chinese Adults' on Oct. 23.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First Affiliated Hospital of Shandong Medical University (Shandong Qianfoshan Hospital)

Condition: Intended for the prevention of RSV infection in preterm infants/newborns

Intervention: RB0026 Injection Solution Group:Single intramuscular injection of 1.5 mg/kg Placebo Group RB0026:Single intramuscular injec...